trending Market Intelligence /marketintelligence/en/news-insights/trending/5g-xnwnsdfj4hhfzdjbc6w2 content esgSubNav
In This List

AstraZeneca focused on new drug launches; Merck Ebola vaccine lands in Congo

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


AstraZeneca focused on new drug launches; Merck Ebola vaccine lands in Congo

Here are the editors' top picks for the week ended May 25.

AstraZeneca CEO says he is focused on new drug launches, not M&A

AstraZeneca PLC, the U.K. drugmaker that has been selling off older blockbuster drugs like the antipsychotic Seroquel, said it is focused on launching a raft of new medicines to drive future growth, rather than acquisitions.

Merck Ebola vaccine lands in DRC; officials discuss other experimental therapies

Four thousand doses of Merck & Co. Inc.'s experimental Ebola vaccine have arrived in the Democratic Republic of the Congo, which has reported 45 cases including 25 deaths from the highly infectious viral disease.

Of Mice Not Men: Cutting cancer at the root, stitching cells into new materials

In this week's column on early stage studies, researchers have found a potential new pathway for immune-based cancer drugs; scientists are building tissuelike material with synthetic cells; others are looking to treat eczema with bacteria.

Trump gets his right-to-try win; FDA chief 'comfortable' after initial criticism

President Donald Trump won the legislation he had pushed Congress for months to pass that would permit Americans to seek experimental treatments without going through the U.S. Food and Drug Administration's compassionate-use process.

HCA CEO details benefits of 'big data,' sees more acquisition opportunities

HCA Healthcare Inc. has invested "tens of millions of dollars" over the last several years to build a clinical data warehouse for digital medical records.

Capitol Checkup: Right-to-try vote; CMS gag threat; new VA pick; NIH Ebola-ready

House Republicans will try to push Senate's right-to-try bill; the Medicare chief says "gag clauses" in drug plans are unacceptable; the acting Veterans Affairs head got a surprise nomination; and the National Institutes of Health is ready for Ebola.

Hospital clinics could face payment cuts under Trump drug plan

In proposing a plan May 11 to lower drug prices, President Trump's administration is also raising the idea of reducing the amount Medicare pays outpatient hospital clinics for administering drugs for chemotherapy and other procedures.